HOME >> BIOLOGY >> NEWS
Update on AIDS vaccine R and D August 24 Web conference

What: Web conference to highlight the state of the AIDS vaccine field and outline bold new initiatives to accelerate AIDS vaccine development included in the AIDS Vaccine Blueprint 2006: Actions to Strengthen Global Research and Development, which launched at the XVI International AIDS Conference in Toronto last week.

IAVI also will preview a series of studies and results to be presented at the 2006 AIDS Vaccine Conference in Amsterdam focused on promoting research and development (R&D); building R&D capacity in developing countries; and expanding R&D resources. There will be a Q&A session for journalists.

Who: Dr. Seth Berkley, CEO and Founder, IAVI Dr. Wayne Koff, Senior Vice President of Vaccine Research, IAVI

When: Thursday August 24 16.00-17.00 CET / 15.00-16.00 GMT / 10.00-11.00 AM EST

Where: Your office. Internet connection and phone line needed to participate.

How: U.S. dial in: 1-877-707-9631; Conference ID: xIAVI. International dial in 1-785-830-1914; Conference ID: xIAVI.

To view PPT slides: Log on to: www.connexpresents.com five minutes prior to start time. Select the [Participant Login] icon. "Attend Event" screen will appear and you will be asked to enter the following information: - Name and number of the presentation: xiavi - Your name - Your company - Click the green [Continue] button to participate in the presentation

NOTE: If you login too early or the leader has not yet joined, you will receive a message that states "This Presentation is Currently Unavailable." Please try again in a few minutes

Why: With 40 million infections worldwide and 14,000 new infections occurring each day, the AIDS pandemic continues to outpace the global effort at prevention and treatment, damaging societies and undermining social and economic progress in developing countries. The only hope to stop the spread of the HIV
'"/>


22-Aug-2006


Page: 1 2

Related biology news :

1. Update on census of wrlds most endangered cat -- female Amur leopard found dead
2. Updated Iraq survey affirms earlier mortality estimates
3. Updated data on novel HPV vaccine confirms efficacy in large population
4. Update on H2N2 and announcements related to CDCs new organizational structure
5. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
6. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
7. Handicapping tuberculosis may be the way to a better vaccine
8. Developing a more effective vaccine for tuberculosis
9. New target for HIV/AIDS drugs and vaccine discovered
10. Genomic analysis uncovers new targets for HIV vaccine
11. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: